5:24 PM
 | 
Jun 24, 2014
 |  BC Extra  |  Company News

Mersana, Merck Serono in ADC deal

Mersana Therapeutics Inc. (Cambridge, Mass.) partnered with EMD Serono, the biopharmaceutical division of Merck KGaA (Xetra:MRK), to discover and co-develop next-generation antibody-drug conjugates...

Read the full 102 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >